Concepedia

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306)

Ryan Sobel, Paul Nyirjesy, MA Ghannoum, D Delchev, NE Azie, D Angulo, IA Harriott, Katyna Borroto–Esoda, J. D. Sobel

BJOG An International Journal of Obstetrics & Gynaecology · 2021 · 50 citations · 19 references

Open access

Abstract

Ibrexafungerp is statistically superior to placebo for the treatment of vulvovaginal candidiasis.

References

19

Sexually transmitted diseases treatment guidelines (2015)

Kimberly Workowski, Gail Bolan · Reproductive Endocrinology · 2015 · 2.7K citations · Full text

Sexual Health, Contraception, Treatment And Prevention +9

Sexually Transmitted Diseases Treatment Guidelines, 2010

Kimberly Workowski, Gail Bolan · Annals of Emergency Medicine · 2011 · 2.1K citations · Full text

Contraception, Sexual Health, Treatment And Prevention +9

Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

Junko Yano, Jack D. Sobel, Paul Nyirjesy et al. · BMC Women s Health · 2019 · 251 citations · Full text

Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole

Jack D. Sobel, PETER KAPERNICK, Marcus Zervos et al. · American Journal of Obstetrics and Gynecology · 2001 · 158 citations

Sequential Doses, Antifungal Agent, Vaginitis +4

Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis)

Werner Mendling · Mycoses · 2015 · 117 citations · Full text